Sentences with phrase «cancer research professor»

Executive Vice President Director, Vaccine & Immunotherapy Center W.W. Smith Charitable Trust Professor in Cancer Research Professor, Immunology, Microenvironment & Metastasis Program

Ingram Professor of Cancer Research Professor of Medicine (Gastroenterology, Hepatology and Nutrition) Professor of Cell and Developmental Biology

Published on Sunday in the journal Nature Cell Biology, in addition to Gomis, the authors include Angel R. Nebreda, ICREA and BBVA Cancer Research Professor, and Eduard Batlle, ICREA Professor and head of the Colorectal Cancer Lab, both at IRB Barcelona.

Not exact matches

Leaning toward the IARC position is Andrew Chan, an associate professor of medicine at Harvard Medical School whose research focuses on colorectal cancer prevention.

Dr. Larry Corey, Principal Investigator, HIV Vaccine Trials Network; Past President and Director, Fred Hutchinson Cancer Research Center Dr. Diane Havlir, Professor of Medicine, University of California, San Francisco Moderator: Siobhan O'Connor, Time Magazine

In an accompanying editorial, Theodore Slotkin, a professor of pharmacology and cancer biology at the Duke University School of Medicine in Durham, North Carolina, writes that it's undeniable that smoking while pregnant contributes to later behavior problems in children, based on the new study and past research.

Health campaigners have welcomed the ban, with professor Alex Markham, chief executive of Cancer Research UK saying: «Today's announcement kicks off the final countdown to a healthier England and to thousands of lives saved.»

Professor Robert West, Cancer Research UK's director of tobacco studies at the Health Behaviour Research Centre at UCL, said: «The smoke - free law has been a huge boost to smokers trying to quit, but radical action is now needed to build on this success.»

Science and Technology — Subject: Clinical trials Witness (es): Professor Karol Sikora, Medical Director of Cancer Partners UK and Dean, University of Buckingham Medical School and Simon Denegri, NIHR National Director for Public Participation and Engagement in Research and Chair, INVOLVE; Tracey Brown, Managing Director, Sense About Science and Dr Helen Jamison, Deputy Director, Science Media Centre; Sir Kent Woods, Chief Executive,, Dr Janet Wisely, Chief Executive, Health Research Authority, Bill Davidson, Acting Deputy Director and Head of Research Standards and Support, Department of Health and Peter Knight, Deputy Director, Head of Research Information and Intelligence, Department of Health Location: Room 8, Palace of Westminster

Professor Stephen Duffy, lead researcher and Cancer Research UK's professor of cancer screening, said: «The results of our study showed that the NHS breast cancer screening programme has been even more effective at saving lives than we pProfessor Stephen Duffy, lead researcher and Cancer Research UK's professor of cancer screening, said: «The results of our study showed that the NHS breast cancer screening programme has been even more effective at saving lives than we predCancer Research UK's professor of cancer screening, said: «The results of our study showed that the NHS breast cancer screening programme has been even more effective at saving lives than we pprofessor of cancer screening, said: «The results of our study showed that the NHS breast cancer screening programme has been even more effective at saving lives than we predcancer screening, said: «The results of our study showed that the NHS breast cancer screening programme has been even more effective at saving lives than we predcancer screening programme has been even more effective at saving lives than we predicted.

Synthetic marijuana was first developed in the South Carolina lab of a Clemson University professor as part of research into therapies for osteoporosis, liver disease and some kinds of cancer.

«Our study suggests that epigenetic changes to cells treated with cigarette smoke sensitize airway cells to genetic mutations known to cause lung cancers,» says Stephen Baylin, M.D., the Virginia and D.K. Ludwig Professor for Cancer Research and professor of oncology at the Johns Hopkins Kimmel CanceProfessor for Cancer Research and professor of oncology at the Johns Hopkins Kimmel Canceprofessor of oncology at the Johns Hopkins Kimmel Cancer Center.

«Once this novel tumor - homing agent binds to the EphA2 receptor, the oncogene functions as a cancer - specific molecular Trojan horse for paclitaxel, carrying the drug inside the cancel cell, killing the cell, and thwarting metastasis,» said Maurizio Pellecchia, a professor of biomedical sciences at UCR's School of Medicine who led the research.

June, a professor in immunotherapy at the University of Pennsylvania, described recent triumphs in cancer research that have now been used to treat more than 300 children with leukemia, all of whom remain in remission.

«Our findings suggest that teens and young adults who seek indoor tanning may be especially vulnerable to developing BCC, the most common form of skin cancer, at a young age,» said lead author Professor Margaret Karagas, co-director of the Cancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at Dartcancer, at a young age,» said lead author Professor Margaret Karagas, co-director of the Cancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at DartCancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at DartCancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at Dartmouth.

«The fine particles of this drug allow for it to be released slowly and stay in the abdomen,» said Katherine Roby, Ph.D., research associate professor in the Department of Anatomy and Cell Biology at KU Medical Cancer, who started her pre-clinical work on Nanotax more than a decade ago.

For this study, Yanik's team developed a new technology to inject RNA carried by nanoparticles called lipidoids, previously designed by Daniel Anderson, an associate professor of chemical engineering, member of the Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, and an author of the new paper.

Professor Charlie Swanton, NCRI chair and Cancer Research UK scientist at the Francis Crick Institute, said: «These are worrying findings.

Tal Danino, a professor at the Data Science Institute, is conducting research that could help scientists combat the most lethal of cancers: pancreatic cancer.

«Despite new therapies, it's virtually inevitable that a patient with multiple myeloma will experience relapse of the disease at some point,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, Koman Family Presidential Endowed Chair in Cancer Research and chief of the Division of Regenerative Medicine at UC San Diego School of Medicine.

Survivors of melanoma were more likely to limit exposure to the sun than people who had never had the disease, but some still reported seeking out suntans and getting sunburns, reports a new article in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research by Rachel Isaksson Vogel, PhD, an assistant professor in the Department of Obstetrics, Gynecology and Women's Health at the University of Minnesota.

Institute researchers Dr Ashley Ng, Dr Maria Kauppi, Professor Warren Alexander, Professor Don Metcalf and colleagues from the institute's Cancer and Haematology and Molecular Medicine divisions led the research, published in the journal Proceedings of the National Academy of Sciences.

Professor Richard Marais, director of the Cancer Research UK Manchester Institute, said: «Malignant melanoma is the most deadly form of skin cancer precisely because it spreads quickly and aggressCancer Research UK Manchester Institute, said: «Malignant melanoma is the most deadly form of skin cancer precisely because it spreads quickly and aggresscancer precisely because it spreads quickly and aggressively.

«These are early results completed on three different types of cancer and we accept that more research needs to be done; but these results so far are remarkable,» said Professor Anderson.

«Everything we talked about was about research directly on the embryo,» for example, to improve on infertility treatment or better understand cancer biology, says R. Alta Charo, a law professor and bioethicist at the University of Wisconsin Law School who was a member of the NIH Human Embryo Research Panel in the mid-1990s, which considered how embryos might be used in rresearch directly on the embryo,» for example, to improve on infertility treatment or better understand cancer biology, says R. Alta Charo, a law professor and bioethicist at the University of Wisconsin Law School who was a member of the NIH Human Embryo Research Panel in the mid-1990s, which considered how embryos might be used in rResearch Panel in the mid-1990s, which considered how embryos might be used in researchresearch.

Professor Paolo Boffetta (MD), the Annals of Oncology associate editor for epidemiology and Director of the Institute of Translational Epidemiology at the Icahn School of Medicine at Mount Sinai in New York (USA), commented: «These results are extremely important in showing that reducing cancer mortality can be achieved: priority should be given to research in cancers with unfavourable trends, such as pancreatic cancer, and in reducing cancer mortality disparities, both between countries (Central / Eastern versus Western Europe), and within countries, for example, between socioeconomic groups.

«These are not magic bullets,» says Solomon Hamburg, a clinical professor of medicine at the UCLA School of Medicine and CEO of Tower Cancer Research Foundation in Beverly Hills.

Professor Arnie Purushotham, Cancer Research UK's senior clinical adviser, said: «One of the challenges when treating early stage breast cancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curinCancer Research UK's senior clinical adviser, said: «One of the challenges when treating early stage breast cancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curincancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curing her.

«This study forms the basis for future research in patients with breast cancer and offers hope for targeted therapy for patients with aggressive triple - negative inflammatory breast cancer,» said lead researcher Mateusz Opyrchal, M.D., Ph.D., Assistant Professor of Oncology at RPCI.

«The study results are extremely suggestive that changes in diet might impact both how an individual responds to primary therapy and their chances of lethal disease spreading later in life,» said the study's senior author, Gregory J. Hannon, PhD, professor of Cancer Molecular Biology and director, Cancer Research UK Cambridge Institute, University of Cambridge in England.

Professor Robert Huddart, Professor of Urological Cancer at The Institute of Cancer Research, London, and Consultant at The Royal Marsden NHS Foundation Trust, said:

Professor Tavassoli adds: «The main application for this work is that it eliminates the need for the synthesis of our inhibitor, so that biologists conducting research into HIF function can easily access our molecule and hopefully discover more about the role of HIF - 1 in cancer.

«We show that high dietary saturated fat content is associated with increased prostate cancer aggressiveness,» said Emma H. Allott, PhD, a research assistant professor in the UNC Gillings School of Global Public Health.

The research team, including Soumen Paul, Ph.D., associate professor, Arindam Paul, Ph.D., assistant professor, and Ossama Tawfik, professor, M.D., Ph. D., all in the Department of Pathology and Laboratory Medicine, and their colleagues, studied atypical protein kinase c lambda / iota signaling during the invasive progression of triple - negative breast cancer.

Professor Andrew Biankin, a Cancer Research UK pancreatic cancer expert at the University of Glasgow, said: «PRECISION Panc aims to transform how we treat pancreatic cancer by matching the right treatment to the right paCancer Research UK pancreatic cancer expert at the University of Glasgow, said: «PRECISION Panc aims to transform how we treat pancreatic cancer by matching the right treatment to the right pacancer expert at the University of Glasgow, said: «PRECISION Panc aims to transform how we treat pancreatic cancer by matching the right treatment to the right pacancer by matching the right treatment to the right patient.

Study leader Professor Janet Shipley, Professor of Cancer Molecular Pathology at The Institute of Cancer Research, London, said:

Other UT Southwestern faculty members who contributed to this research are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Mresearch are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal MResearch and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal MResearch and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Medicine;

Until now, EGFR inhibitors have only been effective at treating the 10 to 15 percent of non-small cell lung cancers that have a variant of EGFR, but the two - drug combo could potentially work for all non-small cell lung cancers, explained Dr. John Minna, Director of the Hamon Center for Therapeutic Oncology Research and Professor of Internal Medicine and Pharmacology.

«However, a problem with almost all research on hematopoiesis in past decades is that it has been restricted to experiments in culture or using transplantation into mice,» says Professor Hans - Reimer Rodewald from the German Cancer Research Center (Deutsches Krebsforschungszentrumresearch on hematopoiesis in past decades is that it has been restricted to experiments in culture or using transplantation into mice,» says Professor Hans - Reimer Rodewald from the German Cancer Research Center (Deutsches KrebsforschungszentrumResearch Center (Deutsches Krebsforschungszentrum, DKFZ).

UTSW co-authors include: Co-lead author Maria Winter, a research associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver DResearch, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Diseases.

«When someone is thinking about joining my group I am very up front with what my expectations are,» says PI Paul Doetsch, professor and distinguished chair in cancer research, at Emory University School of Medicine in Atlanta, Georgia, adding that one major expectation he has for his lab members is a strong work ethic.

«It was kind of fun being at a medical school and known as the weird guy who worked with dogs,» says Modiano, who is now a professor of comparative oncology at the University of Minnesota College of Veterinary Medicine and the Masonic Cancer Center, where his research focuses on immunology, cancer cell biology, cancer genetics, and applications of gene thCancer Center, where his research focuses on immunology, cancer cell biology, cancer genetics, and applications of gene thcancer cell biology, cancer genetics, and applications of gene thcancer genetics, and applications of gene therapy.

«If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,» said Dr. David Wong, a senior author of the research and UCLA's Felix and Mildred Yip Endowed Professor in Dentistry.

Today, an article published in Cancer Discovery by Manel Esteller, Director of the Epigenetics and Cancer Biology Program of Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona, explains that this RNA also has its own spelling and grammar, just like DNA.

«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.

«This approach offers a potentially new and safe way of treating liver cancer, and possibly other cancers,» said study senior author Dr. Ian Corbin, Assistant Professor in the Advanced Imaging Research Center (AIRC) and of Internal Medicine at UT Southwestern.

«Further research into the detailed mechanisms underlying ASIS in naked mole - rats may shed new light on cancer resistance in the mole - rats and contribute to the generation of non-tumorigenic human - iPSCs, enabling safer cell - based therapeutics,» said Kyoko Miura, an assistant professor at Hokkaido University.

Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I / II clinical trial as early as Spring 2015.

«Our study shows that protein production in neurons is one of the major utilizers of energy and that neurons of Leigh syndrome degenerate because they can't sustain a high enough level of energy,» says Tony Hunter, the Renato Dulbecco Chair and American Cancer Society Professor in Salk's Molecular and Cell Biology Laboratory, who led the research.

A team under Professor Scheffler, consisting of researchers from the Bonn University Hospital, the Life & Brain Center, The German Consortium for Translational Cancer Research, Tufts University Boston / Massachusetts, and other institutes in the USA, has now developed a new method that is expected to combat such complex brain tumors better.